(Q37108920)

18 August 2017

Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

18 August 2017

0 references

1 reference

2

Oye Gureje

1 reference

18 August 2017

8

Shekhar Saxena

1 reference

18 August 2017

1

Dan Chisholm

1 reference

18 August 2017

Sandra Saldivia

3

1 reference

18 August 2017

Marcelo Villalón Calderón

4

1 reference

18 August 2017

Rajitha Wickremasinghe

5

1 reference

18 August 2017

Nalaka Mendis

6

1 reference

18 August 2017

Jose-Luis Ayuso-Mateos

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

18 August 2017

10

1 reference

Bulletin of the World Health Organization

inferred from page(s)

published in

1 reference

18 August 2017

86

1 reference

18 August 2017

7

1 reference

18 August 2017

542-551

1 reference

Chlorpromazine versus placebo for schizophrenia

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Cost-effectiveness of an essential mental health intervention package in Nigeria

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Methods to assess the costs and health effects of interventions for improving health in developing countries

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Evaluation of current strategies and future priorities for improving health in developing countries

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

A systematic review of the prevalence of schizophrenia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Econometric estimation of country-specific hospital costs

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Recovery from psychotic illness: a 15- and 25-year international follow-up study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Family-based intervention for schizophrenic patients in China. A randomised controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Survey of psychiatric morbidity in a semi-urban population in Sri Lanka

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Cost-effectiveness evaluation of compliance therapy for people with psychosis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Community outreach for untreated schizophrenia in rural India: a follow-up study of symptoms, disability, family burden and costs.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Assessing cost-effectiveness of drug interventions for schizophrenia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Using the effect size to model change in preference values from descriptive health status

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Assessing cost-effectiveness in mental health: family interventions for schizophrenia and related conditions.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Resource utilisation for neuropsychiatric disorders in developing countries: a multinational Delphi consensus study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Cost-effectiveness of current and optimal treatment for schizophrenia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Evaluation of a community-based rehabilitation model for chronic schizophrenia in rural India.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Estimating the prevalence of schizophrenia in Spain using a disease model

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647485

Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial

4 December 2018

1 reference

12 December 2020

Reducing the global burden of depression

1 reference

12 December 2020

Excess mortality of mental disorder

1 reference

12 December 2020

Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables

1 reference

12 December 2020

Identifiers

DOI

10.2471/BLT.07.045377

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18670667

1 reference